183 related articles for article (PubMed ID: 27012814)
1. Chaperonin Containing TCP-1 Protein Level in Breast Cancer Cells Predicts Therapeutic Application of a Cytotoxic Peptide.
Bassiouni R; Nemec KN; Iketani A; Flores O; Showalter A; Khaled AS; Vishnubhotla P; Sprung RW; Kaittanis C; Perez JM; Khaled AR
Clin Cancer Res; 2016 Sep; 22(17):4366-79. PubMed ID: 27012814
[TBL] [Abstract][Full Text] [Related]
2. The CT20 peptide causes detachment and death of metastatic breast cancer cells by promoting mitochondrial aggregation and cytoskeletal disruption.
Lee MW; Bassiouni R; Sparrow NA; Iketani A; Boohaker RJ; Moskowitz C; Vishnubhotla P; Khaled AS; Oyer J; Copik A; Fernandez-Valle C; Perez JM; Khaled AR
Cell Death Dis; 2014 May; 5(5):e1249. PubMed ID: 24853427
[TBL] [Abstract][Full Text] [Related]
3. PSMA-Targeted Theranostic Nanocarrier for Prostate Cancer.
Flores O; Santra S; Kaittanis C; Bassiouni R; Khaled AS; Khaled AR; Grimm J; Perez JM
Theranostics; 2017; 7(9):2477-2494. PubMed ID: 28744329
[TBL] [Abstract][Full Text] [Related]
4. Targeting chaperonin containing TCP1 (CCT) as a molecular therapeutic for small cell lung cancer.
Carr AC; Khaled AS; Bassiouni R; Flores O; Nierenberg D; Bhatti H; Vishnubhotla P; Manuel JP; Santra S; Khaled AR
Oncotarget; 2017 Dec; 8(66):110273-110288. PubMed ID: 29299146
[TBL] [Abstract][Full Text] [Related]
5. Elucidation of Therapeutic Peptide Binding Partners from Isolated Mitochondria.
Mozayan A; Khaled A
Cureus; 2018 Jun; 10(6):e2898. PubMed ID: 30397556
[TBL] [Abstract][Full Text] [Related]
6. Rational development of a cytotoxic peptide to trigger cell death.
Boohaker RJ; Zhang G; Lee MW; Nemec KN; Santra S; Perez JM; Khaled AR
Mol Pharm; 2012 Jul; 9(7):2080-93. PubMed ID: 22591113
[TBL] [Abstract][Full Text] [Related]
7. Investigating Chaperonin-Containing TCP-1 subunit 2 as an essential component of the chaperonin complex for tumorigenesis.
Showalter AE; Martini AC; Nierenberg D; Hosang K; Fahmi NA; Gopalan P; Khaled AS; Zhang W; Khaled AR
Sci Rep; 2020 Jan; 10(1):798. PubMed ID: 31964905
[TBL] [Abstract][Full Text] [Related]
8. Chaperonin containing TCP-1 (CCT/TRiC) is a novel therapeutic and diagnostic target for neuroblastoma.
Cox A; Nierenberg D; Camargo O; Lee E; Khaled AS; Mazar J; Boohaker RJ; Westmoreland TJ; Khaled AR
Front Oncol; 2022; 12():975088. PubMed ID: 36185250
[TBL] [Abstract][Full Text] [Related]
9. Polyglutamined expanded androgen receptor interacts with chaperonin CCT.
Pongtepaditep S; Limjindaporn T; Lertrit P; Srisawat C; Limwongse C
Eur J Med Genet; 2012 Nov; 55(11):599-604. PubMed ID: 22796525
[TBL] [Abstract][Full Text] [Related]
10. Programmed cell death protein 5 interacts with the cytosolic chaperonin containing tailless complex polypeptide 1 (CCT) to regulate β-tubulin folding.
Tracy CM; Gray AJ; Cuéllar J; Shaw TS; Howlett AC; Taylor RM; Prince JT; Ahn NG; Valpuesta JM; Willardson BM
J Biol Chem; 2014 Feb; 289(7):4490-502. PubMed ID: 24375412
[TBL] [Abstract][Full Text] [Related]
11. Subunits of the chaperonin CCT interact with F-actin and influence cell shape and cytoskeletal assembly.
Brackley KI; Grantham J
Exp Cell Res; 2010 Feb; 316(4):543-53. PubMed ID: 19913534
[TBL] [Abstract][Full Text] [Related]
12. Functional profiling of asymmetrically-organized human CCT/TRiC chaperonin.
Araki K; Suenaga A; Kusano H; Tanaka R; Hatta T; Natsume T; Fukui K
Biochem Biophys Res Commun; 2016 Dec; 481(3-4):232-238. PubMed ID: 27806916
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma.
Cui X; Hu ZP; Li Z; Gao PJ; Zhu JY
World J Gastroenterol; 2015 Jul; 21(28):8588-604. PubMed ID: 26229401
[TBL] [Abstract][Full Text] [Related]
14. Two members of the TRiC chaperonin complex, CCT2 and TCP1 are essential for survival of breast cancer cells and are linked to driving oncogenes.
Guest ST; Kratche ZR; Bollig-Fischer A; Haddad R; Ethier SP
Exp Cell Res; 2015 Mar; 332(2):223-35. PubMed ID: 25704758
[TBL] [Abstract][Full Text] [Related]
15. The chaperonin CCT promotes the formation of fibrillar aggregates of γ-tubulin.
Pouchucq L; Lobos-Ruiz P; Araya G; Valpuesta JM; Monasterio O
Biochim Biophys Acta Proteins Proteom; 2018 Apr; 1866(4):519-526. PubMed ID: 29339327
[TBL] [Abstract][Full Text] [Related]
16. The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells.
Ligumsky H; Wolf I; Israeli S; Haimsohn M; Ferber S; Karasik A; Kaufman B; Rubinek T
Breast Cancer Res Treat; 2012 Apr; 132(2):449-61. PubMed ID: 21638053
[TBL] [Abstract][Full Text] [Related]
17. Disrupting CCT-β : β-tubulin selectively kills CCT-β overexpressed cancer cells through MAPKs activation.
Liu YJ; Kumar V; Lin YF; Liang PH
Cell Death Dis; 2017 Sep; 8(9):e3052. PubMed ID: 28906489
[TBL] [Abstract][Full Text] [Related]
18. Intracellular beta-tubulin/chaperonin containing TCP1-beta complex serves as a novel chemotherapeutic target against drug-resistant tumors.
Lin YF; Tsai WP; Liu HG; Liang PH
Cancer Res; 2009 Sep; 69(17):6879-88. PubMed ID: 19690144
[TBL] [Abstract][Full Text] [Related]
19. The co-chaperone BAG3 interacts with the cytosolic chaperonin CCT: new hints for actin folding.
Fontanella B; Birolo L; Infusini G; Cirulli C; Marzullo L; Pucci P; Turco MC; Tosco A
Int J Biochem Cell Biol; 2010 May; 42(5):641-50. PubMed ID: 20018251
[TBL] [Abstract][Full Text] [Related]
20. CCT2 Mutations Evoke Leber Congenital Amaurosis due to Chaperone Complex Instability.
Minegishi Y; Sheng X; Yoshitake K; Sergeev Y; Iejima D; Shibagaki Y; Monma N; Ikeo K; Furuno M; Zhuang W; Liu Y; Rong W; Hattori S; Iwata T
Sci Rep; 2016 Sep; 6():33742. PubMed ID: 27645772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
